Development of cardiovascular bypass grafts: endothelialization and applications of nanotechnology

References

• Urban P, De Benedetti E. Thrombosis: the last frontier of coronary stenting? Lancet369(9562), 619–621 (2007).
   PubMedGoogle Scholar
• Hannan E, Racz MJ, Walford G et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N. Engl. J. Med.352(21), 2174–2183 (2005).
   PubMed Web of Science ®Google Scholar
• Seung KB, Park DW, Kim YH et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N. Engl. J. Med.358(17), 1781–1792 (2008).
   PubMed Web of Science ®Google Scholar
• Kannan RY, Salacinski HJ, Butler PE, Hamilton G, Seifalian AM. Current status of prosthetic bypass grafts: a review. J. Biomed. Mater. Res. B Appl. Biomater.74(1), 570–581 (2005).
   PubMed Web of Science ®Google Scholar
• Xue L, Greisler HP. Biomaterials in the development and future of vascular grafts. J. Vasc. Surg.37(2), 472–480 (2003).
   PubMed Web of Science ®Google Scholar
• Stewart SF , Lyman DJ. Effects of a vascular graft/natural artery compliance mismatch on pulsatile flow. J. Biomech.25(3), 297–310 (1992).
   PubMed Web of Science ®Google Scholar
• Sarkar S, Schmitz-Rixen T, Hamilton G, Seifalian AM. Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: a review. Medical Med. Biol. Eng. Comput.45(4), 327–336 (2007).
   PubMed Web of Science ®Google Scholar
• Noh H, Vogler EA. Volumetric interpretation of protein adsorption: competition from mixtures and the Vroman effect. Biomaterials28(3), 405–422 (2007).
   PubMed Web of Science ®Google Scholar
• Hasirci V, Vrana E, Zorlutuna P et al. Nanobiomaterials: a review of the existing science and technology, and new approaches. J. Biomater. Sci. Polym. Ed.17(11), 1241–1268 (2006).
   PubMed Web of Science ®Google Scholar
• Miller DC, Webster TJ, Haberstroh KM. Technological advances in nanoscale biomaterials: the future of synthetic vascular graft design. Expert Rev. Med. Devices1(2), 259–268 (2004).
   PubMed Web of Science ®Google Scholar
• Mironov V, Kasyanov V, Markwald RR. Nanotechnology in vascular tissue engineering: from nanoscaffolding towards rapid vessel biofabrication. Trends Biotechnol.26(6), 338–344 (2008).
   PubMed Web of Science ®Google Scholar
• Seifalian AM, Salacinski HJ, Tiwari A, Edwards A, Bowald S, Hamilton G. In vivo biostability of a poly(carbonate-urea)urethane graft. Biomaterials24(14), 2549–2557 (2003).
   PubMed Web of Science ®Google Scholar
• Sarkar S, Salacinski HJ, Hamilton G, Seifalian AM. The mechanical properties of infrainguinal vascular bypass grafts: their role in influencing patency. Eur. J. Vasc. Endovasc. Surg.31 (6), 627–636 (2006).
   PubMed Web of Science ®Google Scholar
• Kannan RY, Salacinski HJ, De GJ et al. The antithrombogenic potential of a polyhedral oligomeric silsesquioxane (POSS) nanocomposite. Biomacromolecules7(1), 215–223 (2006).
   PubMed Web of Science ®Google Scholar
• Kannan RY, Salacinski HJ, Sales KM, Butler PE, Seifalian AM. The endothelialization of polyhedral oligomeric silsesquioxane nanocomposites: an in vitro study. Cell Biochem. Biophys.45(2), 129–136 (2006).
   PubMed Web of Science ®Google Scholar
• Punshon G, Sales KM, Vara DS, Hamilton G, Seifalian AM. Assessment of the potential of progenitor stem cells extracted from human peripheral blood for seeding a novel vascular graft material. Cell Prolif.41(2), 321–335 (2008).
   PubMedGoogle Scholar
• Hoenig MR, Campbell GR, Campbell JH. Vascular grafts and the endothelium. Endothelium13(6), 385–401 (2006).
   PubMed Web of Science ®Google Scholar
• Zilla P, von OU, Deutsch M. The endothelium: a key to the future. J. Card. Surg.8(1), 32–60 (1993).
   PubMed Web of Science ®Google Scholar
• Salacinski HJ, Tai NR, Punshon G, Giudiceandrea A, Hamilton G, Seifalian AM. Optimal endothelialisation of a new compliant poly(carbonate-urea)urethane vascular graft with effect of physiological shear stress. Eur. J. Vasc. Endovasc. Surg.20(4), 342–352 (2000).
   PubMed Web of Science ®Google Scholar
• Herring M, Gardner A, Glover J. Single-staged technique for seeding vascular grafts with autogenous endothelium. Surgery84(4), 498–504 (1978).
   PubMed Web of Science ®Google Scholar
• Tiwari A, Salacinski HJ, Hamilton G, Seifalian AM. Tissue engineering of vascular bypass grafts: role of endothelial cell extraction. Eur. J. Vasc. Endovasc. Surg.21(3), 193–201 (2001).
   PubMed Web of Science ®Google Scholar
• Kaushal S, Amiel GE, Guleserian KJ et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat. Med.7(9), 1035–1040 (2001).
   PubMed Web of Science ®Google Scholar
• DiMuzio P, Tulenko T. Tissue engineering applications to vascular bypass graft development: the use of adipose-derived stem cells. J. Vasc. Surg.45(Suppl.A), A99–A103 (2007).
   PubMed Web of Science ®Google Scholar
• Bordenave L, Fernandez P, Remy-Zolghadri M, Villars S, Daculsi R, Midy D. In vitro endothelialized ePTFE prostheses: clinical update 20 years after the first realization. Clin. Hemorheol. Microcirc.33(3), 227–234 (2005).
   PubMedGoogle Scholar
• Rotmans JI, Heyligers JM, Verhagen HJ et al.In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation112(1), 12–18 (2005).
   PubMed Web of Science ®Google Scholar
• Silber S. Capturing circulating endothelial progenitor cells: a new concept tested in the HEAING studies. Minerva Cardioangiol.54(1), 1–3 (2006).
   PubMedGoogle Scholar
• Vara DS, Salacinski HJ, Kannan RY, Bordenave L, Hamilton G, Seifalian AM. Cardiovascular tissue engineering: state of the art. Pathol. Biol. (Paris)53(10), 599–612 (2005).
   PubMedGoogle Scholar
• Wu B, Gerlitz B, Grinnell BW, Meyerhoff ME. Polymeric coatings that mimic the endothelium: combining nitric oxide release with surface-bound active thrombomodulin and heparin. Biomaterials28(28), 4047–4055 (2007).
   PubMed Web of Science ®Google Scholar
• Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science231(4736), 397–400 (1986).
   PubMed Web of Science ®Google Scholar
• Girton TS, Oegema TR, Grassl ED, Isenberg BC, Tranquillo RT. Mechanisms of stiffening and strengthening in media-equivalents fabricated using glycation. J. Biomech. Eng.122(3), 216–223 (2000).
   PubMed Web of Science ®Google Scholar
• Isenberg BC, Tranquillo RT. Long-term cyclic distention enhances the mechanical properties of collagen-based media-equivalents. Ann. Biomed. Eng.31(8), 937–949 (2003).
   PubMed Web of Science ®Google Scholar
• Isenburg JC, Simionescu DT, Vyavahare NR. Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid. Biomaterials25(16), 3293–3302 (2004).
   PubMed Web of Science ®Google Scholar
• Thakrar RR, Patel VP, Hamilton G, Fuller BJ, Seifalian AM. Vitreous cryopreservation maintains the viscoelastic property of human vascular grafts. FASEB J.20(7), 874–881 (2006).
   PubMed Web of Science ®Google Scholar
• Bader A, Steinhoff G, Strobl K et al. Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation70(1), 7–14 (2000).
   PubMedGoogle Scholar
• Dardik H, Wengerter K, Qin F et al. Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases. J. Vasc. Surg.35(1), 64–71 (2002).
   PubMedGoogle Scholar
• Kobayashi T, Cooper DK. Anti-Gal, α-Gal epitopes, and xenotransplantation. Subcell. Biochem.32, 229–257 (1999).
   PubMedGoogle Scholar
• Spark JI, Yeluri S, Derham C et al. Incomplete cellular depopulation may explain the high failure rate of bovine ureteric grafts. Br. J. Surg.95(5), 582–585 (2008).
   PubMed Web of Science ®Google Scholar
• Poh M, Boyer M, Solan A et al. Blood vessels engineered from human cells. Lancet365(9477), 2122–2124 (2005).
   PubMed Web of Science ®Google Scholar
• Cheng ST, Chen ZF, Chen GQ. The expression of cross-linked elastin by rabbit blood vessel smooth muscle cells cultured in polyhydroxyalkanoate scaffolds. Biomaterials29(31), 4187–94 (2008).
   PubMed Web of Science ®Google Scholar
• Motlagh D, Allen J, Hoshi R, Yang J, Lui K, Ameer G. Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering. J. Biomed. Mater. Res. A82(4), 907–916 (2007).
   PubMed Web of Science ®Google Scholar
• Gao J, Crapo P, Nerem R, Wang Y. Coexpression of elastin and collagen leads to highly compliant engineered blood vessels. J. Biomed. Mater. Res. A85(4), 1120–1128 (2008).
   PubMed Web of Science ®Google Scholar
• Gong Z, Niklason E. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J.22(6), 1635–1648 (2008).
   PubMed Web of Science ®Google Scholar
• Lepidi S, Abatangelo G, Vindigni V et al.In vivo regeneration of small-diameter (2 mm) arteries using a polymer scaffold. FASEB J.20(1), 103–105 (2006).
   PubMed Web of Science ®Google Scholar
• Remuzzi A, Mantero S, Colombo M et al. Vascular smooth muscle cells on hyaluronic acid: culture and mechanical characterization of an engineered vascular construct. Tissue Eng.10(5–6), 699–710 (2004).
   PubMedGoogle Scholar
• Nieponice A, Soletti, Guan J et al. Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials29(7), 825–833 (2008).
   PubMed Web of Science ®Google Scholar
• Matsumura G, Hibino N, Ikada Y, Kurosawa H, Shin’oka T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials24(13), 2303–2308 (2003).
   PubMed Web of Science ®Google Scholar
• Baguneid MS, Seifalian AM, Salacinski HJ, Murray D, Hamilton G, Walker MG. Tissue engineering of blood vessels. Br. J. Surg.93(3), 282–290 (2006).
   PubMed Web of Science ®Google Scholar
• Baguneid M, Murray D, Salacinski HJ et al. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes. Biotechnol. Appl. Biochem.39(Pt 2), 151–157 (2004).
   PubMed Web of Science ®Google Scholar
• L‘Heureux N, Dusserre N, Konig G et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat. Med.12(3), 361–365 (2006).
   PubMed Web of Science ®Google Scholar
• L‘Heureux N, McAllister TN, de la Fuente M. Tissue-engineered blood vessel for adult arterial revascularization. N. Engl. J. Med.357(14), 1451–1453 (2007).
   PubMed Web of Science ®Google Scholar
• Campbell JH, Efendy J, Campbell GR. Novel vascular graft grown within recipient’s own peritoneal cavity. Circ. Res.85(12), 1173–1178 (1999).
   PubMed Web of Science ®Google Scholar
• Cao Y, Zhang B, Croll T et al. Engineering tissue tubes using novel multilayered scaffolds in the rat peritoneal cavity. J. Biomed. Mater. Res. A PMID: 18200539 (2008) (Epub ahead of print).
   Google Scholar
• Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Froschl A, Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann. Thorac. Surg.71(5 Suppl.), S327–S331 (2001).
   PubMed Web of Science ®Google Scholar
• Laube HR, Duwe J, Rutsch W, Konertz W. Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts. J. Thorac. Cardiovasc. Surg.120(1), 134–141 (2000).
   PubMed Web of Science ®Google Scholar
• Gabbieri D, Dohmen PM, Koch C, Lembcke A, Rutsch W, Konertz W. Aortocoronary endothelial cell-seeded polytetrafluoroethylene graft: 9-year patency. Ann. Thorac. Surg.83(3), 1166–1168 (2007).
   PubMedGoogle Scholar
• Rashid ST, Fuller B, Hamilton G, Seifalian AM. Tissue engineering of a hybrid bypass graft for coronary and lower limb bypass surgery. FASEB J.22(6), 2084–2089 (2008).
   PubMed Web of Science ®Google Scholar
• Tai NR, Giudiceandrea A, Salacinski HJ, Seifalian AM, Hamilton G. In vivo femoropopliteal arterial wall compliance in subjects with and without lower limb vascular disease. J. Vasc. Surg.30(5), 936–945 (1999).
   PubMed Web of Science ®Google Scholar
• Kannan RY, Salacinski HJ, Butler PE, Seifalian AM. Polyhedral oligomeric silsesquioxane nanocomposites: the next generation material for biomedical applications. Acc. Chem. Res.38(11), 879–84 (2005).
   PubMed Web of Science ®Google Scholar
• Kannan RY, Salacinski HJ, Edirisinghe MJ, Hamilton G, Seifalian AM. Polyhedral oligomeric silsequioxane-polyurethane nanocomposite microvessels for an artificial capillary bed. Biomaterials27(26), 4618–4626 (2006).
   PubMed Web of Science ®Google Scholar
• Kannan RY, Salacinski HJ, Odlyha M, Butler PE, Seifalian AM. The degradative resistance of polyhedral oligomeric silsesquioxane nanocore integrated polyurethanes: an in vitro study. Biomaterials27(9), 1971–1979 (2006).
   PubMed Web of Science ®Google Scholar
• Gopakumar TG, Xanthos M, Xanthos M. Effect of nanofillers on the properties of flexible protective polymer coatings. Polymer Composites27(4), 368–380 (2006).
   Google Scholar
• Gupta A, Seifalian AM, Ahmad Z, Edirisinghe MJ, Winslet MC. Novel electrohydrodynamic printing of nanocomposite biopolymer scaffolds. J. Bioact. Compat. Polym.22(3), 265–280 (2007).
   Web of Science ®Google Scholar
• Kidane AG, Edirisinghe MJ, Bonhoeffer P, Seifalian AM. Flow behaviour of a POSS biopolymer solution. Biorheology44(4), 265–272 (2007).
   PubMedGoogle Scholar
• Kotch FW, Raines RT. Self-assembly of synthetic collagen triple helices. Proc. Natl Acad. Sci. USA103(9), 3028–3033 (2006).
   PubMed Web of Science ®Google Scholar
• Woolfson DN, Ryadnov MG. Peptide-based fibrous biomaterials: some things old, new and borrowed. Curr. Opin. Chem. Biol.10(6), 559–567 (2006).
   PubMed Web of Science ®Google Scholar
• Miao M, Cirulis JT, Lee S, Keeley FW. Structural determinants of cross-linking and hydrophobic domains for self-assembly of elastin-like polypeptides. Biochemistry44(43), 14367–14375 (2005).
   PubMed Web of Science ®Google Scholar
• Bellingham CM, Lillie MA, Gosline JM et al. Recombinant human elastin polypeptides self-assemble into biomaterials with elastin-like properties. Biopolymers70(4), 445–455 (2003).
   PubMed Web of Science ®Google Scholar
• Gauba V, Hartgerink JD. Self-assembled heterotrimeric collagen triple helices directed through electrostatic interactions. J. Am. Chem. Soc.129(9), 2683–2690 (2007).
   PubMedGoogle Scholar
• Endo M, Koyama S, Matsuda Y, Hayashi T, Kim YA. Thrombogenicity and blood coagulation of a microcatheter prepared from carbon nanotube – nylon-based composite. Nano Lett.5(1), 101–105 (2005).
   PubMed Web of Science ®Google Scholar
• Koyama S, Haniu H, Osaka K et al. Medical application of carbon-nanotube-filled nanocomposites: the microcatheter. Small2(12), 1406–1411 (2006).
   PubMed Web of Science ®Google Scholar
• Kim JY, Khang D, Lee JE, Webster TJ. Decreased macrophage density on carbon nanotube patterns on polycarbonate urethane. J. Biomed. Mater. Res. A (2008).
   Google Scholar
• Hurt RH, Monthioux M, Kane A. Toxicology of carbon nanomaterials: status, trends, and perspectives on the special issue. Carbon44(6), 1028–1033 (2006).
   Web of Science ®Google Scholar
• Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc. Res.78(3), 413–421 (2008).
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Asahara T. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Catheter Cardiovasc. Interv.70(4), 477–484 (2007).
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Losordo DW. Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc. Med.18(1), 33–37 (2008).
   PubMed Web of Science ®Google Scholar
• Adams B, Xiao Q, Xu Q. Stem cell therapy for vascular disease. Trends Cardiovasc. Med.17(7), 246–251 (2007).
   PubMed Web of Science ®Google Scholar
• Hwang NS, Varghese S, Elisseeff J. Controlled differentiation of stem cells. Adv. Drug Deliv. Rev.60(2), 199–214 (2008).
   PubMed Web of Science ®Google Scholar
• Dawson E, Mapili G, Erickson K, Taqvi S, Roy K. Biomaterials for stem cell differentiation. Adv. Drug Deliv. Rev.60(2), 215–228 (2008).
   PubMed Web of Science ®Google Scholar
• Saha K, Pollock JF, Schaffer DV, Healy KE. Designing synthetic materials to control stem cell phenotype. Curr. Opin. Chem. Biol.11(4), 381–387 (2007).
   PubMed Web of Science ®Google Scholar
• Chai C, Leong KW. Biomaterials approach to expand and direct differentiation of stem cells. Mol. Ther.15(3), 467–480 (2007).
   PubMed Web of Science ®Google Scholar
• Alobaid N, Salacinski HJ, Sales KM et al. Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells: an in vitro evaluation. Eur. J. Vasc. Endovasc. Surg.32(1), 76–83 (2006).
   PubMed Web of Science ®Google Scholar
• de Mel A, Jell G, Stevens M, Seifalian AM. Biofunctionalisation of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules (2008)
   PubMedGoogle Scholar
• Miller DC, Thapa A, Haberstroh KM, Webster TJ. Endothelial and vascular smooth muscle cell function on poly(lactic-co-glycolic acid) with nano-structured surface features. Biomaterials25(1), 53–61 (2004).
   PubMed Web of Science ®Google Scholar
• Miller DC, Haberstroh KM, Webster TJ. Mechanism(s) of increased vascular cell adhesion on nanostructured poly(lactic-co-glycolic acid) films. J. Biomed. Mater. Res. A.73A(4), 476–484 (2005).
   Web of Science ®Google Scholar
• Miller DC, Haberstroh KM, Webster TJ. PLGA nanometer surface features manipulate fibronectin interactions for improved vascular cell adhesion. J. Biomed. Mater. Res. A81A(3), 678–684 (2007).
   Web of Science ®Google Scholar
• Pham QP, Sharma U, Mikos AG. Electrospinning of polymeric nanofibers for tissue engineering applications: a review. Tissue Eng.12(5), 1197–1211 (2006).
   PubMedGoogle Scholar
• Murugan R, Ramakrishna S. Nano-featured scaffolds for tissue engineering: a review of spinning methodologies. Tissue Eng.12(3), 435–447 (2006).
   PubMedGoogle Scholar
• Norman JJ, Desai TA. Methods for fabrication of nanoscale topography for tissue engineering scaffolds. Ann. Biomed. Eng.34(1), 89–101 (2006).
   PubMed Web of Science ®Google Scholar
• Barnes CP, Sell SA, Boland ED, Simpson DG, Bowlin G. Nanofiber technology: designing the next generation of tissue engineering scaffolds. Adv. Drug Deliv. Rev.59(14), 1413–1433 (2007).
   PubMed Web of Science ®Google Scholar
• Lee SJ, Yoo JJ, Lim GJ, Atala A, Stitzel J. In vitro evaluation of electrospun nanofiber scaffolds for vascular graft application. J. Biomed. Mater. Res. A83(4), 999–1008 (2007).
   PubMed Web of Science ®Google Scholar
• Stankus JJ, Soletti L, Fujimoto K, Hong Y, Vorp DA, Wagner WR. Fabrication of cell microintegrated blood vessel constructs through electrohydrodynamic atomization. Biomaterials28(17), 2738–2746 (2007).
   PubMed Web of Science ®Google Scholar
• Xu J, Zhou X, Ge H et al. Endothelial cells anchoring by functionalized yeast polypeptide. J. Biomed. Mater. Res. A PMID: 18228253 (2008) (Epub ahead of print).
   Google Scholar
• He W, Ma Z, Teo WE et al. Tubular nanofiber scaffolds for tissue engineered small-diameter vascular grafts. J. Biomed. Mater. Res. A PMID: 18491396 (2008) (Epub ahead of print).
   Google Scholar
• Matsusaki M, Sakaguchi H, Serizawa T, Akashi M. Controlled release of vascular endothelial growth factor from alginate hydrogels nano-coated with polyelectrolyte multilayer films. J. Biomater. Sci. Polym. Ed.18(6), 775–783 (2007).
   PubMed Web of Science ®Google Scholar
• Huang M, Vitharana SN, Peek J, Coop T, Berkland C. Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor. Biomacromolecules8(5), 1607–1614 (2007).
   PubMed Web of Science ®Google Scholar
• Huang M, Berkland C. Controlled release of Repifermin(R) from polyelectrolyte complexes stimulates endothelial cell proliferation. J. Pharm. Sci. PMID: 18425807 (2008) (Epub ahead of print).
   Google Scholar
• Boura C, Muller S, Vautier D et al. Endothelial cell - interactions with polyelectrolyte multilayer films. Biomaterials26(22), 4568–4575 (2005).
   PubMedGoogle Scholar
• Zhong Y, Whittington CF, Haynie DT. Stimulated release of small molecules from polyelectrolyte multilayer nanocoatings. Chem. Commun. (Camb.)14(14), 1415–1417 (2007).
   Web of Science ®Google Scholar
• Ahmad Z, Zhang HB, Farook U, Edirisinghe M, Stride E, Colombo P. Generation of multilayered structures for biomedical applications using a novel tri-needle coaxial device and electrohydrodynamic flow. J. R. Soc. Interface5(27), 1255–1261 (2008).
   PubMed Web of Science ®Google Scholar
• Cohen-Sela E, Rosenzweig O, Gao J et al. Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis. J. Control. Release113(1), 23–30 (2006).
   PubMed Web of Science ®Google Scholar
• Lim HJ, Nam HY, Lee BH, Kim DJ, Ko JY, Park JS. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts. Biotechnol. Prog.23(3), 693–697 (2007).
   PubMed Web of Science ®Google Scholar
• Perea H, Aigner J, Heverhagen JT, Hopfner U, Wintermantel E. Vascular tissue engineering with magnetic nanoparticles: seeing deeper. J. Tissue Eng. Regen. Med.1(4), 318–321 (2007).
   PubMedGoogle Scholar
• Chen S, Hilcove S, Ding S. Exploring stem cell biology with small molecules. Mol. Biosyst.2(1), 18–24 (2006).
   PubMedGoogle Scholar
• Schugar RC, Robbins PD, Deasy BM. Small molecules in stem cell self-renewal and differentiation. Gene Ther.15(2), 126–135 (2008).
   PubMed Web of Science ®Google Scholar
• Ding S, Schultz PG. A role for chemistry in stem cell biology. Nat. Biotechnol.22(7), 833–840 (2004).
   PubMed Web of Science ®Google Scholar
• Xu YY, Li YJ, Guan H et al. The effect of vascular endothelia growth factor encapsulated in nanoparticles on chronic limb ischemia. Zhonghua Wai Ke Za Zhi42(1), 58–61 (2004).
   PubMedGoogle Scholar
• Yla-Herttuala S, Rissanen TT, Vajanto I, Hartikainen J. Vascular endothelial growth factors - biology and current status of clinical applications in cardiovascular medicine. J. Am. Coll. Card.49(10), 1015–1026 (2007).
   PubMed Web of Science ®Google Scholar
• Hughes GA. Nanostructure-mediated drug delivery. Nanomedicine1(1), 22–30 (2005).
   PubMed Web of Science ®Google Scholar
• Zweers M, Engbers GH, Grijpma DW, Feijen J. Release of anti-restenosis drugs from poly(ethylene oxide)-poly(D-lactic-co-glycolic acid) nanoparticles. J. Control. Release114(3), 317–324 (2006).
   PubMed Web of Science ®Google Scholar
• Mei L, Sun H, Jin X et al. Modified paclitaxel-loaded nanoparticles for inhibition of hyperplasia in a rabbit arterial balloon injury model. Pharm. Res.24(5), 955–962 (2007).
   PubMed Web of Science ®Google Scholar
• Westedt U, Kalinowski M, Wittmar M et al. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. J. Control. Release119(1), 41–51 (2007).
   PubMed Web of Science ®Google Scholar
• Fields RC, Solan A, McDonagh KT, Niklason E, Lawson JH. Gene therapy in tissue-engineered blood vessels. Tissue Eng.9(6), 1281–1287 (2003).
   PubMedGoogle Scholar
• Yla-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet355(9199), 213–222 (2000).
   PubMed Web of Science ®Google Scholar
• Gaffney MM, Hynes SO, Barry F, O’Brien T. Cardiovascular gene therapy: current status and therapeutic potential. Br. J. Pharmacol.152(2), 175–188 (2007).
   PubMed Web of Science ®Google Scholar
• Rissanen TT, Yla-Herttuala S. Current status of cardiovascular gene therapy. Mol. Ther.15(7), 1233–1247 (2007).
   PubMed Web of Science ®Google Scholar
• Conte MS. Molecular engineering of vein bypass grafts. J. Vasc. Surg.45, 74A–81A (2007).
   Google Scholar
• Jabr-Milane van V, Devalapally H et al. Multi-functional nanocarriers for targeted delivery of drugs and genes. J. Control. Release130(2), 121–128 (2008).
   PubMed Web of Science ®Google Scholar
• Alexander JH, Hafley G, Harrington RA et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA294(19), 2446–2454 (2005).
   PubMed Web of Science ®Google Scholar
• Berceli SA, Hevelone ND, Lipsitz SR et al. Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J. Vasc. Surg.46(6), 1173–1179 (2007).
   PubMedGoogle Scholar
• Conte MS, Bandyk DF, Clowes AW et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J. Vasc. Surg.43(4), 742–751 (2006).
   PubMed Web of Science ®Google Scholar
• Banno H, Takei Y, Muramatsu T, Komori K, Kadomatsu K. Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J. Vasc. Surg.44(3), 633–641 (2006).
   PubMed Web of Science ®Google Scholar
• Luo ZY, Akita GY, Date T et al. Adenovirus-mediated expression of β-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs. Circulation111(13), 1679–1684 (2005).
   PubMedGoogle Scholar
• Petrofski JA, Hata JA, Williams M et al. A Gβγ inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts. J. Thorac. Cardiovasc. Surg.130(6), 1683–1690 (2005).
   PubMedGoogle Scholar
• Petrofski JA, Hata JA, Gehrig TR et al. Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia. J. Thorac. Cardiovasc. Surg.127(1), 27–33 (2004).
   PubMedGoogle Scholar
• Wolff RA, Ryomoto M, Stark VE et al. Antisense to transforming growth factor-β1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1. J. Vasc. Surg.41(3), 498–508 (2005).
   PubMed Web of Science ®Google Scholar
• Schepers A, Eefting D, Bonta PI et al. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol.26(9), 2063–2069 (2006).
   PubMed Web of Science ®Google Scholar
• Egashira K, Nakano K, Ohtani K et al. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys. Arterioscler. Thromb. Vasc. Biol.27(12), 2563–2568 (2007).
   PubMedGoogle Scholar
• Miyake T, Aoki M, Shiraya S et al. Inhibitory effects of NFκB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. J. Mol. Cell Cardiol.41(3), 431–440 (2006).
   PubMed Web of Science ®Google Scholar
• Miyake T, Aoki M, Morishita R. Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFκB and E2F in a rabbit model. Cardiovasc. Res.79(4), 706–14 (2008).
   PubMedGoogle Scholar
• Andrade JD, Hlady V. Protein adsorption and materials biocompatibility - a tutorial review and suggested hypotheses. Adv. Polymer Sci.79, 1–63 (1986).
   Web of Science ®Google Scholar
• Kidane AG, Salacinski H, Tiwari A, Bruckdorfer KR, Seifalian AM. Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces. Biomacromolecules5(3), 798–813 (2004).
   PubMed Web of Science ®Google Scholar
• Sarkar S, Sales KM, Hamilton G, Seifalian AM. Addressing thrombogenicity in vascular graft construction. J. Biomed. Mater. Res. B Appl. Biomater.82(1), 100–108 (2007).
   PubMed Web of Science ®Google Scholar
• Devine C, Hons B, McCollum C. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trial. J. Vasc. Surg.33(3), 533–539 (2001).
   PubMed Web of Science ®Google Scholar
• Devine C, McCollum C. Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial. J. Vasc. Surg.40(5), 924–931 (2004).
   PubMed Web of Science ®Google Scholar
• Bosiers M, Deloose K, Verbist J et al. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results. J. Vasc. Surg.43(2), 313–318 (2006).
   PubMed Web of Science ®Google Scholar
• Verma S, Marsden PA. Nitric oxide-eluting polyurethanes–vascular grafts of the future? N. Engl. J. Med.353(7), 730–731 (2005).
   PubMed Web of Science ®Google Scholar
• Ahanchi SS, Tsihlis ND, Kibbe MR. The role of nitric oxide in the pathophysiology of intimal hyperplasia. J. Vasc. Surg.45, 64A–73A (2007).
   Google Scholar
• Frost MC, Reynolds MM, Meyerhoff ME. Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices. Biomaterials26(14), 1685–1693 (2005).
   PubMed Web of Science ®Google Scholar
• Miller MR, Megson I. Review - recent developments in nitric oxide donor drugs. Br. J. Pharmacol.151(3), 305–321 (2007).
   PubMed Web of Science ®Google Scholar
• Keefer K. Biomaterials: thwarting thrombus. Nat. Mater.2(6), 357–358 (2003).
   PubMedGoogle Scholar
• Zhang H, Annich GM, Miskulin J et al. Nitric oxide-releasing fumed silica particles: synthesis, characterization, and biomedical application. J. Am. Chem. Soc.125(17), 5015–5024 (2003).
   PubMed Web of Science ®Google Scholar
• Kapadia MR, Chow W, Tsihlis ND et al. Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. J. Vasc. Surg.47(1), 173–182 (2008).
   PubMed Web of Science ®Google Scholar
• Ishii Y, Sakamoto S, Kronengold RT et al. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency. J. Thorac. Cardiovasc. Surg.135(6), 1237–1245 (2008).
   PubMed Web of Science ®Google Scholar
• Tseng PY, Jordan SW, Sun X, Chaikof E. Catalytic efficiency of a thrombomodulin-functionalized membrane-mimetic film in a flow model. Biomaterials27(13), 2768–2775 (2006).
   PubMed Web of Science ®Google Scholar
• Hashi CK, Zhu Y, Yang GY et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc. Natl Acad. Sci. USA104(29), 11915–11920 (2007).
   PubMed Web of Science ®Google Scholar
• Chua KN, Chai C, Lee PC et al. Surface-aminated electrospun nanofibers enhance adhesion and expansion of human umbilical cord blood hematopoietic stem/progenitor cells. Biomaterials27(36), 6043–6051 (2006).
   PubMed Web of Science ®Google Scholar
• Shih YR, Chen CN, Tsai SW, Wang YJ, Lee OK. Growth of mesenchymal stem cells on electrospun type I collagen nanofibers. Stem Cells24(11), 2391–2397 (2006).
   PubMed Web of Science ®Google Scholar
• Davis ME, Motion JP, Narmoneva DA et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation111(4), 442–450 (2005).
   PubMed Web of Science ®Google Scholar
• Carampin P, Conconi MT, Lora S et al. Electrospun polyphosphazene nanofibers for in vitro rat endothelial cells proliferation. J. Biomed. Mater. Res. A80(3), 661–668 (2007).
   PubMedGoogle Scholar
• Feng SS, Zeng W, Teng Y et al. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment. Nanomed.2(3), 333–344 (2007).
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Soheili M. Production and in vitro characterization of lisinopril-loaded nanoparticles for the treatment of restenosis in stented coronary arteries. J. Microencapsul.1–9 (2008).
   PubMedGoogle Scholar
• Gou M, Li X, Dai M et al. A novel injectable local hydrophobic drug delivery system: biodegradable nanoparticles in thermo-sensitive hydrogel. Int. J. Pharm.359(1-2), 228–33 (2008).
   PubMed Web of Science ®Google Scholar
• Banai S, Chorny M, Gertz SD et al. Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries. Biomaterials26(4), 451–461 (2005).
   PubMed Web of Science ®Google Scholar
• Deshpande D, Devalapally H, Amiji M. Enhancement in anti-proliferative effects of paclitaxel in aortic smooth muscle cells upon co-administration with ceramide using biodegradable polymeric nanoparticles. Pharm. Res. (2008).
   PubMedGoogle Scholar
• Cyrus T, Zhang H, Allen JS et al. Intramural delivery of rapamycin with αvβ3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury. Arterioscler. Thromb. Vasc. Biol.28(5), 820–826 (2008).
   PubMed Web of Science ®Google Scholar
• Lanza GM, Winter PM, Caruthers SD et al. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles. Nanomed.1(3), 321–329 (2006).
   PubMed Web of Science ®Google Scholar
• Kolodgie FD, John M, Khurana C et al. Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel. Circulation106(10), 1195–1198 (2002).
   PubMed Web of Science ®Google Scholar
• Epstein H, Berger V, Levi I et al. Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats. J. Control. Release117(3), 322–332 (2007).
   PubMed Web of Science ®Google Scholar